Stocksigma LogoStocksigma Logo

Eiko Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 1,772 (+51.8% YoY | +5.8% QoQ) ■ EBITDA: 223 (+26.6% YoY | +15.3% QoQ) ■ EBITDA Margin (%): 12.6 (-251 bps YoY | +104 bps QoQ) ■ PAT: 135

Eiko Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Eiko Lifesciences Ltd · Outcome · 05 Nov 2026, 10:27 pm

Eiko Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 1,772 (+51.8% YoY | +5.8% QoQ) ■ EBITDA: 223 (+26.6% YoY | +15.3% QoQ) ■ EBITDA Margin (%): 12.6 (-251 bps YoY | +104 bps QoQ) ■ PAT: 135 (+25.6% YoY | +3.3% QoQ) ■ EPS (INR): 0.78 (+0.0% YoY | +2.6% QoQ) Eiko Lifesciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) Segmental Performance Speciality Chemicals & Pharma Intermediates ■ Revenue: 1,630 (+59.0% YoY | +6.9% QoQ) ■ EBIT: 123 (+71.2% YoY | +24.9% QoQ) ■ EBIT Margin (%): 7.6 (+54 bps YoY | +109 bps QoQ) Logistics Services ■ Revenue: 142 (+0.0% YoY | -5.1% QoQ) ■ EBIT: 31.2 (+1.9% YoY | +8.8% QoQ) ■ EBIT Margin (%): 22.0 (+42 bps YoY | +281 bps QoQ)

Original exchange filing (PDF)

More announcements from Eiko Lifesciences Ltd

All Eiko Lifesciences Ltd announcements